(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
Quarter results tomorrow
(bmo 2024-05-20)
Expected move: +/- 8.33%
-1.70% $ 1.730
Live Chart Being Loaded With Signals
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain...
Stats | |
---|---|
Volumen de hoy | 45 224.00 |
Volumen promedio | 64 693.00 |
Capitalización de mercado | 11.20M |
EPS | $0 ( 2024-03-29 ) |
Próxima fecha de ganancias | ( $-0.790 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.480 |
ATR14 | $0.0300 (1.72%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Werner Milton H. | Buy | 45 000 | Stock Option (right to buy) |
2024-04-01 | Lees-rolfe Garth | Buy | 90 000 | Stock Option (right to buy) |
2024-04-01 | Lees-rolfe Garth | Sell | 5 834 | Stock Option (right to buy) |
2023-06-30 | Berman Dennis N | Buy | 6 667 | Stock Option (right to buy) |
2023-06-30 | Dion Gisele | Buy | 6 667 | Stock Option (right to buy) |
INSIDER POWER |
---|
96.37 |
Last 62 transactions |
Buy: 1 923 769 | Sell: 2 120 717 |
Volumen Correlación
Inhibikase Therapeutics, Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Inhibikase Therapeutics, Correlación - Moneda/Commodity
Inhibikase Therapeutics, Finanzas
Annual | 2023 |
Ingresos: | $260 500 |
Beneficio Bruto: | $83 102.00 (31.90 %) |
EPS: | $-3.57 |
FY | 2023 |
Ingresos: | $260 500 |
Beneficio Bruto: | $83 102.00 (31.90 %) |
EPS: | $-3.57 |
FY | 2022 |
Ingresos: | $123 440 |
Beneficio Bruto: | $116 717 (94.55 %) |
EPS: | $-4.26 |
FY | 2021 |
Ingresos: | $3.10M |
Beneficio Bruto: | $3.10M (100.00 %) |
EPS: | $-0.810 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Inhibikase Therapeutics,
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointestinal complications that arise as early symptoms of PD, such as swallowing, dysphagia, neurogenic constipation, and multiple system atrophy; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects and for the treatment of blood and stomach cancers. It is also involved in developing various research programs for other neurological diseases. The company has research and development collaborations with The Johns Hopkins University, Arizona State University, and Michigan State University, as well as Louisiana State University. Inhibikase Therapeutics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico